Phase II study of photodynamic therapy and metal stent as palliative treatment for nonresectable hilar cholangiocarcinoma

Gastrointestinal Endoscopy

Volumn 57, Issue 7, 2003, Pages 860-867

  Dumoulin, Franz Ludwig ^a   Gerhardt, Thomas ^a   Fuchs, Sybille ^a   Scheurlen, Christian ^a   Neubrand, Michael ^a   Layer, Günter ^a   Sauerbruch, Tilman ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; METAL; PHOTOFRIN; PLASTIC; PORFIMER NATRIUM; UNCLASSIFIED DRUG;

AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT TUMOR; BILIARY TRACT DRAINAGE; BILIOMA; BILIRUBIN BLOOD LEVEL; CHOLANGITIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROL GROUP; CONTROLLED STUDY; ENDOPROSTHESIS; EVALUATION; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HILAR CHOLANGIOCARCINOMA; HUMAN; MALE; MORTALITY; OVERALL SURVIVAL; PALLIATIVE THERAPY; PERITONITIS; PHASE 2 CLINICAL TRIAL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RETROSPECTIVE STUDY; SENSITIZATION; SKIN TOXICITY; STATISTICAL SIGNIFICANCE; STENT; THERAPY EFFECT; INTRAHEPATIC BILE DUCT; MIDDLE AGED; PHOTOCHEMOTHERAPY;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; PHOTOCHEMOTHERAPY; PROSPECTIVE STUDIES; STENTS;

EID: 0141721808     PISSN: 00165107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5107(03)70021-2     Document Type: Article

References (37)

1. de Groen P., Gores G., LaRusso N., Gunderson L., and Nagorney D. Biliary tract cancers. N Engl J Med 341 (1999) 1368-1378
2. Reding R., Buard J., Lebeau G., and Launois B. Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 213 (1991) 236-241
3. Burke E., Jarnagin W., Hochwald S., Pisters P., Fong Y., and Blumgart L. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228 (1998) 385-394
4. Chamberlain R., and Blumgart L. Hilar cholangiocarcinoma: a review and commentary. Ann Surg Oncol 7 (2000) 55-66
5. Jarnagin W. Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19 (2000) 156-176
6. Bismuth H., Nakache R., and Diamond T. Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215 (1992) 31-38
7. Reed Jr. D., Vitale G., Martin R., Bas H., Wieman T., Larson G., et al. Bile duct carcinoma: trends in treatment in the nineties. Am Surg 66 (2000) 711-715
8. Vauthey J., and Blumgart L. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 14 (1994) 109-114
9. Todoroki T. Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery. Hepatogastroenterology 47 (2000) 644-649
10. McMasters K., Tuttle T., Leach S., Rich T., Cleary K., Evans D., and Curley S. Neoadjuvant chemoradiation for extrahepatic cholangiocarcinoma. Am J Surg 174 (1997) 605-608
11. Sanz-Altamira P., Ferrante K., Jenkins R., Lewis W., Huberman M., and Stuart K. A phase II trial of 5-fluorouracil, leucovorin, and carboplatin in patients with unresectable biliary tree carcinoma. Cancer 82 (1998) 2321-2325
12. Sanz-Altamira P., O'Reilly E., Stuart K., Raeburn L., Steger C., Kemeny N., and Saltz L. A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma. Ann Oncol 12 (2001) 501-504
13. Ducreux M., Rougier P., Fandi A., Clavero-Fabri M., Villing A., Fassone F., et al. Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9 (1998) 653-656
14. Pazdur R., Royce M., Rodriguez G., Rinaldi D., Patt Y., Hoff P., and Burris H. Phase II trial of docetaxel for cholangiocarcinoma. Am J Clin Oncol 22 (1999) 78-81
15. Whittington R., Neuberg D., Tester W., Benson III A., and Haller D. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group Trial. J Clin Oncol 13 (1995) 227-232
16. Bowling T., Galbraith S., Hatfield A., Solano J., and Spittle M. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in nonresectable cholangiocarcinoma. Gut 39 (1996) 852-855
17. Ove R., Kennedy A., Darwin P., and Haluszka O. Postoperative endoscopic retrograde high dose-rate brachytherapy for cholangiocarcinoma. Am J Clin Oncol 23 (2000) 559-561
18. De Vreede I., Steers J., Burch P., Rosen C., Gunderson L., Haddock M., et al. Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6 (2000) 309-316
19. Liu C., Lo C., Lai E., and Fan S. Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg 133 (1998) 293-296
20. Lai E., Lo C., and Liu C. Endoscopic stenting for malignant biliary obstruction. World J Surg 25 (2001) 1289-1295
21. Ducreux M., Liguory C., Lefebvre J., Ink O., Choury A., Fritsch J., et al. Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors. Dig Dis Sci 37 (1992) 778-783
22. Polydorou A., Cairns S., Dowsett J., Hatfield A., Salmon P., Cotton P., and Russell R. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 32 (1991) 685-689
23. Schmassmann A., von Gunten E., Knuchel J., Scheurer U., Fehr H., and Halter F. Wallstents versus plastic stents in malignant biliary obstruction: effects of stent patency of the first and second stent on patient compliance and survival. Am J Gastroenterol 91 (1996) 654-659
24. Ortner M. Photodynamic therapy of cholangiocarcinoma cancer. Gastrointest Endosc Clin N Am 10 (2000) 481-486
25. Zoepf T., Jakobs R., Arnold J., Apel D., Rosenbaum A., and Riemann J. Photodynamic therapy for palliation of nonresectable bile duct cancer: preliminary results with a new diode laser system. Am J Gastroenterol 96 (2001) 2093-2097
26. Rumalla A., Baron T., Wang K., Gores G., Stadheim L., and de Groen P. Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc 53 (2001) 500-504
27. Berr F., Tannapfel A., Lamesch P., Pahernik S., Wiedmann M., Halm U., et al. Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma. J Hepatol 32 (2000) 352-357
28. Oleinick N., and Evans H. The photobiology of photodynamic therapy: cellular targets and mechanisms. Radiat Res 150 (1998) S146-S156
29. Hsi R., Rosenthal D., and Glatstein E. Photodynamic therapy in the treatment of cancer: current state of the art. Drugs 57 (1999) 725-734
30. Webber J., Herman M., Kessel D., and Fromm D. Current concepts in gastrointestinal photodynamic therapy. Ann Surg 230 (1999) 12-23
31. McCaughan J., Mertens B., Cho C., Barabash R., and Payton H. Photodynamic therapy to treat tumors of the extrahepatic biliary ducts. A case report. Arch Surg 126 (1991) 111-113
32. Ortner M., Liebetruth J., Schreiber S., Hanft M., Wruck U., Fusco V., et al. Photodynamic therapy of nonresectable cholangiocarcinoma. Gastroenterology 114 (1998) 536-542
33. Berr F., Wiedmann M., Tannapfel A., Halm U., Kohlhaw K., Schmidt F., et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 31 (2000) 291-298
34. Born P., Rösch T., Willkomm G., Sandschin W., Fitz N., Weigert N., et al. Initial experience with a new Yamakawa-type prosthesis for long-term percutaneous transhepatic drainage. Endoscopy 31 (1999) 748-750
35. Aaronson N., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
36. Janda M., Gerstner N., Obermair A., Fuerst A., Wachter S., Dieckmann K., and Potter R. Quality of life changes during conformal radiation therapy for prostate carcinoma. Cancer 89 (2000) 1322-1328
37. Deviere J., Baize M., de Toeuf J., and Cremer M. Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage. Gastrointest Endosc 34 (1988) 95-101